Synectics Share Discussion Threads

[xavico] 12/1/2006 13:01

Papal Power ... definitely right...could do with some update to keep the punters informed and attract more interest.

[papalpower] 04/1/2006 15:52

86p to buy yesterday and 87p to buy today, the slack is getting thinner, and with some news this could move very fast. A trading update would be nice, esp if in this month of January.

[papalpower] 03/1/2006 15:09

Report: India to get 10% of global clinical research market

A new report indicates India will capture about 10% of the global clinical research market within the next five years. The Ernest & Young report says about 30% of clinical research will take place outside the U.S. and Western Europe, with much of the work moving to locations that have advantages of language, patient pool, easy recruitment, and the availability of reliable investigators and institutions.

Pharmabiz.com (India) (Dec/29/05)

[papalpower] 31/12/2005 11:44

noshy, very true. The question is of course how well (good, very good, excellent) Synexus are doing now, long term then yes its a no brainer, short term I will be happy if we see near to the 1.4m profits suggested, that will be a great starting point and also would mean decent growth is there. This will not be a stock for short term traders, and will not likely appeal to most smaller PI's, I think it will appeal to mid to long term investors, and it will appeal to big players and institutions, and therefore rises in the price, will be subject to when big buy orders are placed and also news of more JV's and progress of course. For the coming 12 months I would suggest, as James Crux has above, we can expect a decent rise in the price, just will be difficult to gauge when it will happen, for the coming 24 to 36 months, there is some serious potential gains to be made I think.

I think in India it will be more like a hundreth of the cost, and you pass 25% of that on to your client in their savings, and increase your margins at the same time, the profit making machine starts to churn into action.

[noshy] 31/12/2005 11:25

PP
SNX has been on my monitor since ipo.

my kids have funded part of their uni costs by selling their bodies to drug testing companies, the money can be good £2-3K for a four week residential session. Medeval seem to be a UK leader in this subject.

As a medic, I did not feel too anti this way of raising money, its all ethical etc.

BUT, what if you can do the same in India for a tenth of the cost, yet maintain margins.....no brainer.

I think I will put my toe in the water next week

[papalpower] 30/12/2005 13:55

India's first patient recruitment SMO up and running

Kirsty Barnes

22/12/2005 - UK-based Synexus Clinical Research has formed the first patient-recruitment site management organisation (SMO) in India to cash in on India's burgeoning clinical research market.

The company, the largest patient recruitment organisation in Europe, has achieved this through its strategic alliance with IRL, a subsidiary of the Indian Clinical Research Institute, formed earlier this month.
IRL-Synexus will establish a chain of fully owned good clinical practice (GCP)-compliant clinical research centres across India, and the first of which has now been opened in Mumbai. All patients will be recruited through internationally accepted methods and the first patient is expected to be recruited to a trial in the first three months of 2006, said the company.

India's clinical research industry is currently valued at $100 million (€83 million) and is almost doubling each year, reflecting the shifting focus of the clinical outsourcing industry to Asia.

India's value in clinical research is compelling for many reasons, including significantly lower costs of conducting trials and a large patient population that are treatment naive and thus ideal candidates for clinical trials.

"India possesses tremendous potential to become a preferred location for research and development for the global biotechnology and pharmaceutical sector," Said Dr Ian Smith, medical director of Synexus.

The IRL-Synexus alliance is the first move in the company's new strategy of replicating its UK operations through acquisitions and partnerships across a range of countries important to its clients for running clinical trials.

[papalpower] 30/12/2005 10:48

An extract from www.growthcompany.co.uk 5th Dec 2005 article

Picks for 2006

James Crux
Synexus
Ticker: SNX
Share price: 87.5p
Market cap: £19.0m
52-week high/low: 94.5p/72p

Synexus poised for healthy growth

My tip for the coming year is Synexus, which was recently brought to AIM by Brewin Dolphin with a £3.5 million funding at 65p. It boasts experienced pharmaceuticals entrepreneur Mike Redmond as chairman and specialises in recruiting patients for clinical trials for the global pharmaceutical industry, where clients include such market giants as GlaxoSmithKline and Novartis.

Through its own UK network of investigator sites, the company finds patients, screens them for suitability, and then manages them through the trial before collecting the data and reporting back to clients.

The Synexus model apparently delivers patients faster and at a lower cost than the outdated method of relying on NHS GPs and hospital consultants. Better quality data is another huge plus for its major pharma customers. Large global players are urging Synexus to set up its model in emerging countries like India, Poland and Russia. Profits are forecast to come in at £1.4 million from £10.2 million sales for the year to March. It's my share of the year.

[xavico] 16/12/2005 09:27

PapalPower

Many thanks. Perhaps we'll see a run in the New Year leading upto results. A little tick up here and there would do.

Regards

[papalpower] 15/12/2005 17:01

xavico.

Interim statement is not required, as the period is prior to floating, full year end is March 31st 2006.

The website is being upgraded and the new one should be live end of January, with a proper Investor Relations section.

Should you need any information from them in the meantime I suggest contacting Christopher Neilson (Finance Director and Company Secretary) at

[e-mail]

[papalpower] 13/12/2005 00:43

With this share they could easily be caught with their pants down, another good deal and it could fly again. Large buys on this one will always at the moment be charged ot over the offer price.

[xavico] 12/12/2005 17:09

A nice buy of just under 14,000 at the end of the day at 93p. Seems as if this one ought to be nudging its way north again any day now.

The spread is a bit naughty....the mms dont want to be caught with their trouser's down. After all, it's not a volatile share now is it.

[xavico] 12/12/2005 09:29

PapalPower. I agree with post 34 - it seems any which way up is fine. The buys may be small at the mo' but they're trickling in. As for the interims perhaps snx will wait until the new year before they announce them in which case the share price may continue to tick up gently. All the best.

[papalpower] 11/12/2005 12:07

xavico I am going to try to check to see if the year end dates have changed, or should we be getting interims this month. I can understand them being released to the end of the three month period, if its their first ones on listing and also they have been busy in India for the big deal in November.

[papalpower] 09/12/2005 18:01

A good day with a sell being taken at 2p over the bid price, still think any volume on this one will see a big rise, but gentle buying will see little and often rises, so all is looking good.

[papalpower] 09/12/2005 10:41

xavico I am thinking they will just release the interims and there will not be any advance notice.

[xavico] 09/12/2005 09:34

a couple more buys today tho' not large indicates hopefully some other investors are willing to take a stake in the hope of some good interims.

[xavico] 09/12/2005 09:26

PapalPower...Thanx for the posts. The share price looks as if it is now making some small daily increases and hopefully that will continue. IMHO it is better to have a slow but gradual increase rather than the sometimes quite violent swings some other shares seem to have. Do you expect them to announce the date for interims or simply announce the interims without notice?

[papalpower] 09/12/2005 08:27

Reading the Indian web sites, the deal was signed mid November, exactly around the time the price shot up. Must mean the rumour mill thinks it is a significant deal and worthy of rising the price, and those rumours come from the inside, so have to take it that the deal will mean big things for SNX.

[papalpower] 09/12/2005 02:08

5,000 crore Rupees = A very large amount of dollars ! Past the number of digits on my small calculator ;)


"India possesses tremendous potential to become a preferred location for research and development for the global biotechnology and pharmaceutical sector. According to a McKinsey report, the global clinical trial outsourcing opportunity in India in the pharmaceutical industry is estimated to be around Rs 5,000 crore by the year 2010, and there will be requirement of approximately 50,000 clinical research professionals. Our association with Synexus will certainly help us tap the ever-growing global market," said Dugal.

IRL-Synexus will work in all therapeutic areas where OPD-based studies can be undertaken. It will ensure active patient participation for each clinical study and source patients through internationally accepted recruitment methods.

Vijay Moza, Vice-Chairman and CEO, IRL, said, "Synexus resembles our philosophy, ethics and business values. We are extremely happy to have UK's largest patient recruitment organisation, Synexus as our partner in India. IRL will leverage Synexus's experience, network, and innovative and ethically approved patient recruitment methods."

[papalpower] 08/12/2005 17:37

A significant development for Synexus. The signing of this deal must have been what boosted the share price a few weeks back, it is a big development.

Now all I want is the results to look through the figures in more detail.

[papalpower] 08/12/2005 16:26

Looks like a small buy has lifted the price up again, could be in for some interesting times if volume picks up.

[papalpower] 08/12/2005 11:23

xavico it does, but I think that will not happen in a big way until interims are out and people can then look over the figures, I know a few people waiting for the figures before getting in, and I am sure there are many more like this.

[xavico] 08/12/2005 11:20

PapalPower...let's hope there is more good news in the pipe-line. Still holding and look forward to the interims. This one needs to be put on the radar a bit more.

[papalpower] 08/12/2005 08:54

Seem to be on the move again today.